Latest Insider Transactions at Travere Therapeutics, Inc. (TVTX)
This section provides a real-time view of insider transactions for Travere Therapeutics, Inc. (TVTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Travere Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Travere Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 16
2020
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
2,500
-9.4%
|
$57,500
$23.96 P/Share
|
Nov 16
2020
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-27.81%
|
$172,500
$23.98 P/Share
|
Nov 13
2020
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-21.76%
|
$172,500
$23.61 P/Share
|
Nov 13
2020
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
2,500
-8.6%
|
$57,500
$23.62 P/Share
|
Nov 13
2020
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
2,500
-8.22%
|
$57,500
$23.62 P/Share
|
Nov 11
2020
|
Laura Clague Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+30.32%
|
-
|
Nov 11
2020
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+14.67%
|
-
|
Nov 11
2020
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+14.11%
|
-
|
Nov 06
2020
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
20,625
-8.82%
|
$474,375
$23.0 P/Share
|
Nov 05
2020
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.06%
|
$52,500
$21.26 P/Share
|
Oct 05
2020
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,188
-4.92%
|
$41,572
$19.35 P/Share
|
Oct 02
2020
|
Peter Heerma CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,188
-4.68%
|
$39,384
$18.9 P/Share
|